Friday, September 3, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Drug Discovery
1 of 4
Previous |
Next
Drug Discovery
The downsizing solution
Despite 2006 revenues of more than $45 billion (+2 percent), the world’s largest pharmaceutical company is cutting 10,000 jobs as it tries to cut costs by over $2 billion annually.
No Comments
Two Ways to Improve Drug Discovery Speed and Productivity
“Do more with less” – most of us hear this every day. However, greater workload complexity coupled with resource limitations are putting new demands on drug discovery productivity.
No Comments
The Significance of siRNA Design, Quality, and Delivery
Key Drivers of Performance in the siRNA Workflow
Submitted by Sigma
No Comments
Beyond Gene Therapy: Broad Uses for Lentiviral Vectors
Boro Dropulic, Ph.D., MBA
Founder and CEO, Lentigen Corporation
boro.dropulic@lentigen.com
No Comments
Liquid Handling for Reliable Assay Miniaturization
The bright promise of assay miniaturization has been recognized for well over a decade.
No Comments
1 of 4
Previous |
Next
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.